[Treatment of multiple sclerosis by Azathioprine. About 77 cases studied during 10 years (author's transl)]. 1978

G Aimard, and C Confavreux, and P Trouillas, and M Devic

UI MeSH Term Description Entries
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine

Related Publications

G Aimard, and C Confavreux, and P Trouillas, and M Devic
November 1974, MMW, Munchener medizinische Wochenschrift,
G Aimard, and C Confavreux, and P Trouillas, and M Devic
September 1977, MMW, Munchener medizinische Wochenschrift,
G Aimard, and C Confavreux, and P Trouillas, and M Devic
June 1978, Revista medica de Chile,
G Aimard, and C Confavreux, and P Trouillas, and M Devic
January 1981, Revue neurologique,
G Aimard, and C Confavreux, and P Trouillas, and M Devic
January 1979, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
G Aimard, and C Confavreux, and P Trouillas, and M Devic
January 1978, Annales de dermatologie et de venereologie,
G Aimard, and C Confavreux, and P Trouillas, and M Devic
January 1980, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
G Aimard, and C Confavreux, and P Trouillas, and M Devic
January 1979, Journal de gynecologie, obstetrique et biologie de la reproduction,
G Aimard, and C Confavreux, and P Trouillas, and M Devic
January 1979, Zhonghua nei ke za zhi,
Copied contents to your clipboard!